Business Context and Reporting Period
Company: Alterity Therapeutics Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: November 2019
Date Filed: November 25, 2019
Principal Executive Office: Level 3, 460 Bourke Street, Melbourne, VIC 3000, Australia
This filing serves to incorporate the company's 2019 Annual General Meeting (AGM) Presentation by reference into Registration Statements on Form S-8 and Form F-3.
Key Financial Metrics
The provided filing text does not contain specific financial data. It acts as a cover document referencing an external presentation. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this text.
Material Changes
No material changes regarding financial performance or operations are detailed in this specific filing text. The document solely announces the incorporation of the AGM Presentation.
Guidance, Outlook, and Risks
Management Commentary: The filing indicates that the 2019 AGM Presentation contains the relevant management commentary and outlook, but the text of that presentation is not included in this document.
Risks and Contingencies: No specific risks or contingencies are listed in this filing text.
Unusual Items: None reported in this text.
Investor Verification Checklist
- Locate and review the full "2019 AGM Presentation" referenced in Item 99.1 to obtain actual financial figures and strategic updates.
- Verify the details of the Registration Statements on Form S-8 (File No. 333-228671) and Form F-3 (Files No. 333-220886 and 333-231417) where this presentation is incorporated.
- Confirm the company's status as a Foreign Private Issuer filing under Form 20-F.